Endogenous sex hormones and cardiovascular disease incidence in men.

PubWeight™: 1.22‹?› | Rank: Top 10%

🔗 View Article (PMID 16880459)

Published in Ann Intern Med on August 01, 2006

Authors

Johan Arnlöv1, Michael J Pencina, Shreyasee Amin, Byung-Ho Nam, Emelia J Benjamin, Joanne M Murabito, Thomas J Wang, Philip E Knapp, Ralph B D'Agostino, Shalendar Bhasin, Ramachandran S Vasan

Author Affiliations

1: National Heart, Lung, and Blood Institute's Framingham Heart Study, National Institutes of Health, Bethesda, Maryland, USA.

Articles citing this

Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study. Am J Respir Crit Care Med (2010) 1.57

A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet (2007) 1.42

The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci (2012) 1.13

Life history context of reproductive aging in a wild primate model. Ann N Y Acad Sci (2010) 1.11

Effects of dietary soy protein on iliac and carotid artery atherosclerosis and gene expression in male monkeys. Atherosclerosis (2007) 1.04

Association of sex hormones and C-reactive protein levels in men. Clin Endocrinol (Oxf) (2009) 1.02

Endocrinology of the aging male. Best Pract Res Clin Endocrinol Metab (2011) 0.99

Testosterone and ill-health in aging men. Nat Clin Pract Endocrinol Metab (2009) 0.99

Comparisons of immunoassay and mass spectrometry measurements of serum estradiol levels and their influence on clinical association studies in men. J Clin Endocrinol Metab (2013) 0.97

Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study. Clin Endocrinol (Oxf) (2013) 0.92

Increased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study. J Bone Miner Res (2009) 0.92

Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc (2013) 0.89

Detrimental effects of endogenous oestrogens on primary acute myocardial infarction among postmenopausal women. Neth Heart J (2013) 0.88

Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ Arrhythm Electrophysiol (2014) 0.87

Higher Estradiol and Lower Dehydroepiandrosterone-Sulfate Levels Are Associated with Pulmonary Arterial Hypertension in Men. Am J Respir Crit Care Med (2016) 0.87

A review of the relationships between endogenous sex steroids and incident ischemic stroke and coronary heart disease events. Curr Cardiol Rev (2015) 0.85

Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab (2008) 0.85

Intestinal Microbiota Is Influenced by Gender and Body Mass Index. PLoS One (2016) 0.84

Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: findings from the Framingham Heart Study. J Clin Endocrinol Metab (2011) 0.82

Prognostic value of dehydroepiandrosterone-sulfate and other parameters of adrenal function in acute ischemic stroke. PLoS One (2013) 0.82

Sex steroids and cardiovascular disease. Asian J Androl (2014) 0.82

Derivatization of estrogens enhances specificity and sensitivity of analysis of human plasma and serum by liquid chromatography tandem mass spectrometry. Talanta (2015) 0.81

The relationship between level of androgenic hormones and coronary artery disease in men. Cardiovasc J Afr (2007) 0.78

Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal. J Clin Endocrinol Metab (2010) 0.76

Testosterone and Cardiovascular Disease. Open Cardiovasc Med J (2016) 0.76

Testosterone as a marker of coronary artery disease severity in middle aged males. Indian Heart J (2016) 0.75

Reactive oxygen species: players in the cardiovascular effects of testosterone. Am J Physiol Regul Integr Comp Physiol (2015) 0.75

Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc (2017) 0.75

Articles by these authors

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med (2008) 57.29

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47

Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98

Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95

General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42

Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation (2014) 22.74

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol (2002) 16.25

Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60

Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med (2010) 14.49

Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology (2010) 14.07

Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79

Obesity and the risk of heart failure. N Engl J Med (2002) 12.58

Metabolite profiles and the risk of developing diabetes. Nat Med (2011) 12.22

Genome-wide association study of blood pressure and hypertension. Nat Genet (2009) 11.54

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med (2004) 11.46

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med (2002) 11.20

Adverse events associated with testosterone administration. N Engl J Med (2010) 10.94

The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA (2013) 10.43

Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 10.24

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14

The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. Am J Epidemiol (2007) 9.90

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70

Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med (2008) 9.68

Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation (2010) 9.09

Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91

2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80

Incidence of diabetes in youth in the United States. JAMA (2007) 8.70

Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med (2007) 8.59

Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation (2005) 8.54

Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49

Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension (2004) 8.27

Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54

Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27

The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics (2006) 7.19

Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med (2004) 7.12

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA (2007) 6.95

Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med (2002) 6.92

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA (2002) 6.84

Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation (2003) 6.83

Obesity and the risk of new-onset atrial fibrillation. JAMA (2004) 6.73

Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55

Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med (2004) 6.42

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation (2007) 6.34